Wednesday, Workshop Room

High resolution CT
Moderator: D. Lynch, Denver/US

13:00 Secondary pulmonary lobule anatomy and nodular pattern
H. Prosch, Vienna/AT
13:18 Linear and reticular pattern
F. Molinari, Tourcoing/FR
13:36 GGO opacities and consolidation
M. Silva, Parma/IT
13:54 Approach to cystic lung diseases
A. Oikonomou, Toronto/CA
14:12 How to diagnose fibrotic lung diseases
D. Lynch, Denver/US


Lung nodule management
Moderator: A. Devaraj, London/UK

15:00 Radiological assessment
T. Frauenfelder, Zurich/CH
15:20 Characterization
A.R. Larici, Rome/IT
15:40 Management guidelines
A. Devaraj, London/UK


Chest radiography
Moderator: L. Goodman, Milwaukee/US

16:30 A chest radiography reading guide
M-P. Revel, Paris/FR
16:45 Alveolar, interstitial and nodular syndromes
M. Schiebler, Wisconsin/US
17:00 Lobar atelectasis
A. Leung, Stanford/US
17:15 Pleural syndrome
A.P. Parkar, Bergen/NO
17:30 Mediastinal syndromes
L. Goodman, Milwaukee/US

THURSDAY, MAY 09, 2019

Thursday, Room 1

Scientific Session 1: Lung cancer, nodules and screening
Moderators: P. Grenier, Paris/FR, M. Prokop, Nijmegen/NL

08:30 Low-dose computed tomography (LDCT) screening reduces lung cancer mortality beyond 5 years
M. Silva, Parma/IT
08:40 Lung cancer risk after baseline round of screening: Only 20% of NLST eligibles require annual round
M. Silva, Parma/IT
08:50 Lung Cancer Screening with Ultralow Dose Chest CT: Potential Pitfalls of Pulmonary Findings in Different Readers with Various Experience Levels
K. Martini, Zurich/CH
09:00 Regional polish lung cancer screening program – CT results and lung cancer detection rate
M. Jelitto-Gorska, Gdansk/PL
09:10 Lung cancer screening in an oncologic patient population. Results of our 7 year experience
E. O’Dwyer, New York/US
09:20 Characterization of mediastinal anterior masses with magnetic resonance imaging using diffusion-weighted imaging and prediction of World Health Organization classification
M. Gavrel, Villejuif/FR
09:30 Discussion


Opening Session
Moderators: C. Powell, New York/US; M-P. Revel, Paris/FR

10:00 Welcome from the 2019 congress presidents
C. Powell, New York/US; M-P. Revel, Paris/FR
10:05 Thoracic applications of AI: Threat or opportunity?
E. Siegel, Baltimore/US


Oncology: Lung cancer in 2019

Moderators: L. Bonomo, Rome/IT; S. Sakai, Tokyo/JP

10:30 Current trends in worldwide lung cancer epidemiology
C. Powell, New York/US
10:52 The new TNM system: Changes and limitations
A.R. Larici, Rome/IT
11:14 Immunotherapy: How can imaging help to evaluate the response?
C. Caramella, Villejuif/FR
11:36 Do not forget the patient: Sarcopenia and other comorbidities
F. Goldwasser, Paris/FR
11:58 Discussion


Industry sponsored lunch symposium

Chronic thromboembolic pulmonary hypertension (CTEPH)
M. Remy-Jardin, University Hospital Lille/FR
Clinical outcomes of 3T lung MRI
M. Lederlin, University Hospital Rennes/FR
Clear Direction in CT – Advanced efficiencies for better patient care
B. Schmidt, Head of CT Scanner Applications, Siemens Healthineers, Forchheim/DE


CT lung cancer screening

Moderators: H-U. Kauczor, Heidelberg/DE; H. Prosch, Vienna/AT

13:30 Summary of current evidence, results from the Nelson study
M. Prokop, Nijmegen/NL
13:52 Best technical imaging standards in CT lung cancer screening
A. Snoeckx, Edegem/BE
14:14 Risk models and biomarkers: Do they improve screening?
M. Silva, Parma/IT
14:36 Psychological impact of screening
J. Brodersen, Copenhagen/DK
14:58 US experience after implementation
P. Boiselle, Boston/US
15:20 Discussion


Radiation dose

Moderators: Y. Ohno, Kobe/JP; A.P. Parkar, Bergen/NO

16:00 Dose optimization for thoracic CT: The MEDIRAD project
C. Hoeschen, Magdeburg/DE
16:22 How do I evaluate CT radiation dose
D. Tack, Braine-L’Alleud/BE
16:44 Ultra-low dose CT protocols: Clinical indications
G. Ferretti, Grenoble/FR
17:06 Imaging the lung with no dose: Current role of MRI
J. Biederer, Heidelberg/DE
17:28 Discussion

Thursday, Room 2

Scientific Session 2: AI, radiomics, Prediction Imaging
Moderators: E. Siegel, Baltimore/US; tba

08:30 Automated CT quantification of interstitial lung disease: Comparison between convolutional neural network and ground truth
Y.-W. Kim, Paris/FR
08:40 Deep Muti-Atlas Driven Elastic Nets For segmentation of scleroderma-related ILD on chest CT
G. Chassagnon, Paris/FR
08:50 Deep iodine: Artificial intelligence-based normalized subtraction CT iodine maps for improved detection of pulmonary embolism
D. Grob, Nijmegen/NL
09:00 Performance of an AI-powered lung nodule detection and segmentation algorithm in a patient cohort with histologically confirmed lung tumors
A.W. Sauter, Basel/CH
09:10 CT 3D texture analysis: Differentiation of thymoma from thymic cyst by enhanced CT imaging
S. Lim, Seoul/KR
09:20 Predicting overall survival of lung cancer patients using Radiomics CT features
M.K. Santos, Ribeirao Preto/BR
09:30 Which Imaging Characteristics Predict Recurrence In Stage 3A Lung Cancer After Chemotherapy And Radiation Therapy Treatment?
C. Simmers, New York/US


Functional imaging
Moderators: M. Schiebler, Madison/US; E. van Beek, Edinburgh/UK

10:30 Evaluating the pulmonary perfusion
M. Remy-Jardin, Lille/FR
10:52 Functional imaging in COPD
J.B. Seo, Seoul/KR
11:14 Evaluating the CF patient
M.O. Wielpütz, Heidelberg/DE
11:36 New trends in functional imaging
E. Hoffman, Iowa/US
11:58 Discussion


COPD and other inhalation diseases
Moderators: S. Murayama, Nisihara/JP; J.B. Seo, Seoul/KR

13:30 Current trends in COPD epidemiology and smoking epidemic
S. Raoof, New York/US
13:52 From pathology to imaging: Lessons from micro-CT
J. Hogg, Vancouver/CA
14:14 Smoking-related interstitial lung disease
J. Galvin, Silver Spring/US
14:36 Hypersensitivity pneumonitis: An update
A. Devaraj, London/UK
14:58 Aspiration: Imaging manifestations
J. Ryu, Rochester/US
15:20 Discussion


KSTR and FSTI joint session
Moderators: M. Lederlin, Rennes/FR; J.W. Song, Seoul/KR

16:00 Hemoptysis: KSTR guidelines
J-H. Kim, Daejeon/KR
16:15 Hemoptysis embolization: 10 year experience
A. Khalil, Paris/FR
16:30 Endovascular management of severe hemoptysis in patients with lung transplantation
W. Mohammad, Paris/FR
16:36 Hemoptysis requiring bronchial artery embolization in patients with nontuberculous mycobacteria lung disease
S.S. Shim, Seoul/KR
16:42 Transthoracic rebiopsy for mutation analysis in lung adenocarcinoma: Outcomes and risk factors for non-diagnostic specimen in 199 patients
B. Nam, Seoul/KR
16:48 Diagnostic outcome and safety of CT-guided core needle biopsy for mediastinal mass: A Systematic review and meta-analysis
H.N. Lee, Seoul/KR
16:54 Diagnostic accuracy of CT-guided core biopsy of thin-walled cavitary pulmonary lesions
K.E. Shin, Bucheon-si, Gyeonggi-do/KR
17:00 Efficacy of advanced knowledge-based iterative reconstruction in coronary CT angiography for plaque quantification: A comparison with intravascular ultrasound
J.Y. Yoo, Cheongju-si/KR
17:06 Preoperative CT-determined emphysema and postoperative pulmonary complication for non-small cell lung cancer
H.Y. Lee, Incheon/KR
17:12 Imaging of lung transplantation and common postoperative complications
Y. Choi, Yangsan/KR
17:18 Clinicoradiologic significance of Late-Onset Noninfectious Pulmonary Complications (LONIPCs) after allogenic hematopoietic stem cell transplantation (HSCT)
J.S. Park, Bucheon/KR
17:24 Chest Magnetic Resonance Imaging: Current Applications and Future Perspectives
Y.J. Jeong, Busan/KR

FRIDAY, MAY 10, 2019

Friday, Room 1

Scientific Session 3: Airways COPD
Moderators: A. Bankier, Boston/US; R. Cesar, Golnik/SI

08:30 Prone vs supine posture differences in quantitative CT imaging-derived regional lung ventilation map and motionography in healthy subjects
C. Lee, Seoul/KR
08:40 Numerical Modeling of Hyperpolarized Xenon-129 Gas Transfer in Health and COPD Subjects
O. Doganay, Oxford/UK
08:50 Quantitative computed tomography in the assessment of asthma severity
M. Patyk, Wroclaw/PL
09:00 Comparison of Different Reconstruction Kernel in Quantitative Evaluation of Emphysema on CT
M. Khalil, Gothenburg/SE
09:10 Emphysema in Lung Cancer Screening Program participants – Visual and automatic evaluation
A. Durawa, Gdansk/PL
09:20 Fully automated 3D quantification of “minus” and “plus” pathology in Cystic Fibrosis using 3D-UTE MRI: A validation study
I. Benlala, Bordeaux/FR
09:30 CT Evaluation of hyperattenuating mucus to diagnose allergic bronchopulmonary aspergillosis in the special condition of cystic fibrosis
G. Dournes, Bordeaux/FR
09:40 Derivation und Validation of a Primary Ciliary Dyskinesia Computed Tomography (PCD-CT) Score in adult patients with bronchiectasis
S. Dettmer, Hanover/DE
09:50 Not to be Sniffed At: Role of Diaphragm Fluoroscopy in influencing patient selection for surgical intervention in patients with Diaphragmatic Paralysis
H. Ramotar, Leeds/UK


10:00-10:30 Industry sponsored company slot
Radiation dose management in CT: The role of contrast media

M. Prokop, Radboud University Medical Centre, Nijmegen/NL


Guidelines and practice
Moderators: T. McLoud, Boston/US; H. Prosch, Vienna/AT

11:00 Fleischner Society guidelines for solid and subsolid nodules management
H. MacMahon, Chicago/US
11:20 STR guidelines for evaluating suspected pulmonary embolism during pregnancy
A. Leung, Stanford/US
11:40 Guidelines for lung cancer screening: European and US perspectives
A. Bankier, Boston/US
12:00 Multidisciplinary conferences: Where is and how do we quantify “added value”
J. Verschakelen, Leuven/BE
12:20 Discussion


12:45-13:45 Industry sponsored lunch symposium
Latest innovations for thoracic and cardiovascular CT imaging

Moderator: F. Gleeson, Oxford/UK

Lung cancer screening: which tools for nodule detection and volumetry?
A.R. Larici, Rome/IT
Spectral Imaging use in Chronic Pulmonary Thromboembolism
G. Ferretti, Grenoble/FR
Artificial intelligence: the new way to your best CT image
L. Macron, Saint Denis/FR


Radiomics and deep learning
Moderators: N. Paragios, Paris/FR; E. Siegel, Baltimore/US

14:00 Radiomics: How does it work?
L. Fournier, Paris/FR
14:22 Deep learning: How does it work?
M. Vakalopoulou, Saclay/FR
14:44 Radiomics: Characterization or prognosis tool in lung cancer?
J.M. Goo, Seoul/KR
15:06 Deep learning for classification and quantification of lung fibrosis
G. Chassagnon, Paris/FR
15:28 Deep learning for detection and characterization of lung nodules
B. van Ginneken, Nijmegen/NL
15:50 Discussion


Idiopathic pulmonary fibrosis (IPF): An update
Moderators: P-Y. Brillet, Bobigny/FR; A. Devaraj London/UK

16:30 New IPF criteria: Impact on imaging and treatment
D. Lynch, Denver/US
16:52 Acute exacerbation: Current definition, differentials and imaging features
N. Sverzellati, Parma/IT
17:14 Novel treatments: What have they changed or improved?
A. Wells, London/UK
17:36 Computed Tomographic Biomarkers in Idiopathic Pulmonary Fibrosis
S. Walsh, London/UK
17:58 Discussion

Friday, Room 2

Scientific Session 4: Pulmonary and nodule perfusion, dose reduction and intervention[m1] Moderators: M. Remy-Jardin, Lille/FR; D. Tack, Braine-L’Alleud/BE

08:30 Perfusion defects on dual energy CT angiogram correlate with lower survival in patients with pulmonary embolism
R. Perez Johnston, New York/US
08:40 Intra-patient comparison of pulmonary nodule enhancement in subtraction CT and dual-energy CT
D. Grob, Nijmegen/NL
08:50 CT angiography for pulmonary embolism in the emergency department: Diagnostic accuracy of 20 ml high-concentration contrast medium
G. Milanese, Parma/IT
09:00 Organ-based radiation dose reduction to breast in lung cancer screening with low-dose computed tomography (CT)
P. Franchi, Teramo/IT
09:10 Comparison of ultra-low dose CT scanning protocols for the detection of pulmonary nodules classified according to lungrads: A phantom study
G. Milanese, Parma/IT
09:20 Vertical off-centering in Reduced Dose Chest-CT with Automated Tube Current Modulation: Impact on effective dose and image noise
K. Martini, Zurich/CH
09:30 Study on Radiation Dose in accordance with the Automatic Exposure Control Chamber position on Chest PA
D. Sung, Seoul/KR
09:40 CT-guided microcoil pulmonary nodule localization prior to video-assisted thoracoscopic surgery (VATS): Diagnostic utility and recurrence-free survival
J.C.L. Rodrigues, Bath/UK
09:50 Air embolism – Severe complication of percutaneous lung needle biopsy, which could be avoided
M. Jelitto-Gorska, Gdansk/PL


Vascular diseases
Moderators: C. Beigelman-Aubry, Lausanne/CH; J. Mayo, Vancouver/CA

11:00 Pulmonary hypertension: Role of CT
N. Screaton, Cambridge/UK
11:20 Large vessel vasculitis
E. Castañer González, Sabadell/ES
11:40 Small vessel vasculitis
A-L. Brun, Paris/FR
12:00 Acute aortic syndromes
D. Litmanovich, Boston/US
12:20 Discussion


Acute and chronic pulmonary embolism
Moderators: C. Dennie, Ottawa/CA; M. Remy-Jardin, Lille/FR

14:00 Acute and chronic pulmonary embolism: Diagnostic imaging strategies
L. Haramati, Bronx/US
14:22 The role of CT for risk stratification in acute PE
G. Aviram, Tel-Aviv/IL
14:44 New MR sequences: Current performance and remaining limitations
B. Ghaye, Brussels/BE
15:06 Subsegmental PE: Definition and evidence-based management
C. Schaefer-Prokop, Amersfoort/NL
15:28 Evaluating PE with dual layer CT
E. Coche, Brussels/BE
15:50 Discussion


ESTI meets STR: Infection
Moderators: T. Frauenfelder, Zurich/CH; A. Oikonomou, Toronto/CA

16:30 TB: The role of imaging in the worldwide battle
R. Gill, Lexington/US
16:52 Emerging infections: What can imaging tell us?
T. Franquet, Barcelona/ES
17:14 The many faces of pulmonary aspergillosis: A memoir
W. Gefter, Wynnewood/US
17:36 HIV infection: Current trends with a special focus on Africa and on adolescents
S. Desai, London/UK
17:58 Discussion

SATURDAY, MAY 11, 2019

Saturday, Room 1

ESTI meets ESCR: Assessing the heart on routine, ungated chest CT
Moderators: J. Bremerich, Basle/CH; S. Padley, London/UK

08:30 What to do about incidental extrapulmonary findings in the heart: A practical approach
L. Natale, Rome/IT
08:46 Evaluating the pulmonary veins before and after ablation
M. Das, Duisburg/DE
09:02 Coronary calcium scoring on ungated CT: As useful as dedicated scoring on gated CT?
R. Vliegenthart, Groningen/NL
09:18 Cardiac calcifications: What do they tell us?
F. Pontana, Lille/FR
09:34 Discussion


Film Panel
Moderators: P. Grenier, Paris/FR; N. Howarth, Chêne-Bougeries/CH

Team 1
C. de Margerie-Mellon, Paris/FR; R. Gill, Lexington/US; A. Oikonomou, Toronto/CA; C. Ridge, London/UK

Team 2
L. Goodman, Milwaukee/US; N. Sverzellati, Parma/IT; G. Rubin, Stanford/US; C. White, Baltimore/US


11:45-12:45 Industry sponsored lunch symposium

11:45 Advanced CT imaging in Chest diagnosis
M. Prokop, Radboud University Medical Centre, Nijmegen/NL
12:15 Challenges of Canon 3T MR Imaging for Chest Diseases: Its’ Progress and Future Direction
Y. Ohno, Fujita Health University School of Medicine, Toyoake/JP


Thoracic intervention
Moderators: A. Bankier, Boston/US; J.Y. Gaubert, Marseille/FR

13:00 Percutaneous lung nodule biopsy: Tips & tricks
C. Ridge, London/UK
13:22 Imaging-guided bronchoscopic biopsy: New indications and strategies
13:44 Percutaneous ablation of lung malignancies
J. Klein, Williston/US
14:06 Pleural interventions
F. Gleeson, Oxford/UK
14:28 Closed chest limited anatomical pulmonary resections: The role of new imaging modalities
D. Gossot, Paris/FR
14:50 Discussion


Honorary Membership & Awardings
Moderator: S. Desai, London/UK; M-P. Revel, Paris/FR

15:15 Honorary Lecture “Why I am happy to be a chest radiologist and what I have to do to keep it that way in 10 years”
C. Schaefer-Prokop, Amersfoort/NL

15:35 Awardings


General Assembly
> for active ESTI members!

Saturday, Room 2

Scientific Session 5: ILD
Moderators: A. Devaraj, London/UK; G. Meirelles, Sao Paulo/BR

08:30 Keynote lecture
G. Meirelles, Sao Paulo/BR
08:35 Bronchiolocentric interstitial pneumonia: tomographic patterns of bronchopulmonary abnormalities.
M.K.S. Santos, Ribeirao Preto/BR
08:45 The Sum of Usual Interstitial Pneumonia (UIP) and Emphysema is Equal to Combined Pulmonary Fibrosis and Emphysema (CPFE): A Study of HRCT

Z.N. Tekin, Istanbul/TR
08:55 Increased in- and expiratory CT Density Changes reveal possible Abnormalities in Idiopathic Pulmonary Fibrosis, Hypersensitivity Pneumonitis and Systemic Sclerosis.
A. Poellinger, Bern/CH
09:05 Characterization of interstitial lung disease associated with anti-ribonucleoprotein (RNP) antibodies
P.A. Grenier, Paris/FR
09:15 Characteristics of lung disease patterns on CT scan in patients with idiopathic inflammatory myopathies: is CT pattern related to myositis specific autoantibodies ?
A. Laporte, Neuilly sur seine/FR
09:25 Diagnosis of idiopathic pulmonary fibrosis: comparison of the new and old classification
A. Ottavianelli, Rome/IT
09:35 The impact of chest CT quality in the diagnosis of Usual Interstitial Pneumonia (UIP) pattern
A. Farchione, Rome/IT


ESTI meets KSTR – Oral and poster presentations
Moderators: N. Howarth,Chêne-Bougeries/CH; Y-H. Kim, Gwangju/KR

13:30 A Survey of Institutions with Sixteen Detector-Rows or More CT Scanners for the Introduction of National Lung Cancer Screening Program Using Low-Dose Chest CT in S. Korea
S.H. Paik, Deajeon/KR
13:35 Deep Learning for Classification of A Small (≤2cm) Pulmonary Nodule on CT Imaging: A Preliminary Study
K.J. Chae, Jeonju/KR
13:40 Significance of baseline CT assessment for predicting the pulmonary fibrosis during the course of chemotherapy-induced pneumonitis
J-Y. Han, Busan/KR
13:45 Pleural invasion classification of primary lung cancer by 3T MRI with contrast enhanced radial T1-wieghted 3D spoiled gradient echo sequence comparison with CT analysis
W. Kwon, Wonju/KR
13:50 Long-term outcome after surgical treatment for part-solid lung cancer less than 3 cm: single institutional experience
T.H. Kim, Seoul/KR
13:55 CT-derived Area and Density of Pectoralis Muscle Associated Disease Severity and Longitudinal Change in Chronic Obstructive Pulmonary Disease
S.H. Bak, Chuncheon/KR
14:00 Is it meaningful to evaluate the thyroid attenuation on unenhanced chest CT?
J.J. Woo, Seoul/KR
14:05 Early detection of chronic complicated bronchopleural fistula after pulmonary resection in longitudinal CT follow up
J.W. Baek, Busan/KR
14:10 The use of low dose chest CT in healthcare workers with latent pulmonary tuberculosis
K. Jin, Seoul/KR
14:15 Therapeutic and monitoring devices in the thorax: Radiographic evaluation of findings and complications
J.E. Lee, Gwangju/KR
14:20 Pattern approach of mosaic attenuation: Radiological anatomy and strategy for differentiation.
K.-N. Lee, Busan/KR
14:25 Comorbidities of Lung Emphysema
C.H. Park, Cheonan/KR
14:30 Comparison of digital tomosynthesis and chest radiography for prediction of calcification in pulmonary nodule: A phantom study
S. You, Suwon/KR
14:35 Radiographic findings of intrapulmonary hemorrhage as a complication of clopidogrel use in a patient with acute coronary syndrome
E-S. Lee, Seoul/KR
14:40 Phantom experimental study on radiation dose to doctors using an ambu-bag during head CT scan: Comparison study with non-Pb apron
D. Sung, Seoul/KR
14:45 Diverse clinical and radiologic manifestations of tuberculosis in unusual human bod parts from A TO Z: Nobody shall sneak out of the white death
K.Y. Lee, Ansan/KR
14:50 Tumoral and peritumoral CT radiomics for the prediction of ALK (anaplastic lymphoma kinase) and EGFR (epidermal growth factor receptor) mutation in lung adenocarcinoma
J.B. Seo, Seoul/KR
14:55 Discussion